← Cellectis S.A. CLLS
Market Price
$3.17
Market Cap
$228.17M
P/E Ratio
N/A
Revenue (FY 2025)
↑75.8% YoY
$72.95M
3-Yr CAGR: 56.1%
Net Income
N/A
Net Margin: 0.0%
Free Cash Flow
↑52.7% YoY
$6.07M
FCF Yield: 2.66%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
N/A
ROA: N/A
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (CLLS)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $0.2M | — | $43.3M | $-67.3M | — | — | — | $1.7M | — | — |
| FY 2017 | $42.2M | +26,138.5% | $17.9M | $-4.3M | +93.6% | — | — | $1.4M | $-1.0M | — |
| FY 2018 | $30.1M | -28.7% | $11.4M | $-9.6M | -123.4% | — | — | $6.9M | $2.2M | +316.4% |
| FY 2019 | $30.8M | +2.2% | $3.8M | $-13.1M | -36.1% | — | — | $6.8M | $-6.1M | -378.8% |
| FY 2020 | $82.5M | +167.8% | $37.7M | $-16.4M | -25.1% | — | — | $2.6M | $-43.1M | -605.2% |
| FY 2021 | $67.1M | -18.7% | $25.9M | $-10.9M | +33.5% | — | — | — | — | — |
| FY 2022 | $19.2M | -71.4% | $15.8M | $-7.9M | +27.6% | — | — | — | — | — |
| FY 2023 | $17.6M | -8.0% | $0.0M | $-7.4M | +6.5% | — | — | — | — | — |
| FY 2024 | $41.5M | +135.4% | $38.9M | — | +100.0% | — | — | $6.6M | $4.0M | — |
| FY 2025 | $72.9M | +75.8% | $70.7M | — | — | — | — | $8.4M | $6.1M | +52.7% |
Valuation
Market Price
$3.17
Market Cap
$228.17M
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
N/A
FCF Yield
2.66%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
96.95%
Operating Margin
-45.34%
Net Margin
0.00%
Return on Equity (ROE)
N/A
Return on Assets (ROA)
N/A
Asset Turnover
0.22x
Revenue 3-Yr CAGR
56.12%
Financial Health & Liquidity
Current Ratio
N/A
Cash Ratio
N/A
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
N/A
Total Debt
N/A
Book Value / Share
N/A
Cash Flow Efficiency
Operating Cash Flow
$8.43M
Capital Expenditures (CapEx)
$2.36M
Free Cash Flow
$6.07M
OCF / Revenue
11.55%
FCF / Revenue
8.32%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
N/A
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$324.72M
Total Liabilities
$248.82M
Stockholders' Equity
N/A
Current Assets
N/A
Current Liabilities
N/A